<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Appili Therapeutics Enrolls Participants in Clinical Trials
Image Overlay - Appili Therapeutics Enrolls Participants in Clinical Trials

Appili Therapeutics Enrolls Participants in Clinical Trials

October 29, 2020

Appili Therapeutics Enrolls Participants in Clinical Trials

Canada-based Appili Therapeutics has enrolled and dosed the first cluster of participants in its Phase II CONTROL COVID-19 clinical trial of favipiravi, developed by FUJIFILM Toyama Chemical. Yourway has a local depot that’s 6,000 square feet conveniently located in Toronto, Canada to better serve the clinical trial needs in the country.

Back to Index
Media

Upcoming Events

Global Clinical Supplies Group (GCSG)

October 14-16, 2025
Hungary, Budapest

Clinical Outsourcing Group (COG)

October 21-22, 2025
Burlingame, California

Media

Articles

Case study: Coordinating a complex intercontinental shipment on a short timeline

Open chat
Come chat with us!
Hello! How can I help you?